Zharp2-1, a RIPK2 inhibitor, inhibits the transcription of inflammatory cytokines induced by MDP-induced or Listeria monocytogenes infection and alleviates MDP-induced peritonitis symptoms in mice, which can be used for the study of inflammatory bowel disease (IBD).
Molecular Weight:
383.4
Purity:
99.41%
CAS Number:
[2772600-18-5]
Formula:
C19H18N3O2PS
Target:
RIP kinase
T79600
* VAT and and shipping costs not included. Errors and price changes excepted
